Evaluating the Impact of Oncology Care Model Reporting Requirements on Biomarker Testing and Treatment

PURPOSE: The Oncology Care Model (OCM) is Medicare’s first alternative payment model program for patients with cancer. As of October 2017, participating practices were required to report biomarker testing of patients with advanced non–small-cell lung cancer (aNSCLC). Our objective was to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellanos, Emily H., Orlando, Abigail, Ma, Xinran, Parikh, Ravi B., O’Connell, Gillian, Meropol, Neal J., Hamrick, James, Adamson, Blythe J. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Quality in Action
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564129/
https://www.ncbi.nlm.nih.gov/pubmed/32496874
http://dx.doi.org/10.1200/JOP.19.00747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564129/
https://www.ncbi.nlm.nih.gov/pubmed/32496874
http://dx.doi.org/10.1200/JOP.19.00747

Ejemplares similares